{"id":"W4323050383","doi":"10.1158/1538-7445.sabcs22-p3-07-18","title":"Abstract P3-07-18: CCTG IND.239: A phase 2 study of combined CFI-400945 and durvalumab in patients with advanced triple negative breast cancer (aTNBC)","year":2023,"lang":"en","type":"article","venue":"Cancer Research","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Juravinski Cancer Centre; University Health Network; Hamilton Health Sciences; Princess Margaret Cancer Centre; Ottawa Hospital","funders":"","keywords":"Durvalumab; Medicine; Oncology; Breast cancer; Taxane; Cancer; Internal medicine; Immunotherapy; Pembrolizumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007851929,0.0009609414,0.001488147,0.0003799456,0.0005380205,0.0007516999,0.001067939,0.001240501,0.00873227],"category_scores_gemma":[0.0003643983,0.0004154981,0.00067785,0.0003848039,0.000393004,0.0003775555,0.0002935264,0.002897799,0.001659346],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001264954,"about_ca_system_score_gemma":0.001918378,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.003332074,"about_ca_topic_score_gemma":0.01107251,"domain_scores_codex":[0.999757,0.00007557694,0.0000112294,0.00004036301,0.00004745809,0.00006839813],"domain_scores_gemma":[0.9996177,0.00004016894,0.00004281805,0.00001859597,0.00003334082,0.0002473629],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4171525,0.05199993,0.01157126,0.001812969,0.001526335,0.00162677,0.0003895174,0.003104069,0.2022552,0.0007305229,0.06956202,0.2382689],"study_design_scores_gemma":[0.6742592,0.2614568,0.02879948,0.0001123504,0.0006845156,0.001493975,0.00006941552,0.001831574,0.0124475,0.0002550885,0.01852168,0.00006844057],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9675515,0.005581297,0.0005966208,0.002243848,0.0003440517,0.004997414,0.005788803,0.0002661412,0.01263035],"genre_scores_gemma":[0.9628652,0.003443703,0.002184956,0.002074302,0.0003700725,0.003982234,0.009461734,0.00009809302,0.01551971],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00873227,"threshold_uncertainty_score":0.0292123,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08534702685228639,"score_gpt":0.4775520246060658,"score_spread":0.3922049977537794,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}